Perrigo (PRGO) Research & Development (2012 - 2026)
Perrigo's (PRGO) quarterly Research & Development came in at $129.5 million in Q2 2026, down 5.13% year-over-year from $136.5 million in Q2 2025, and little changed quarter-over-quarter from $129.7 million in Q1 2026.
Analysis
Perrigo (PRGO) Research & Development (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Research & Development for 15 consecutive years, with $129.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Research & Development fell 5.13% year-over-year to $129.5 million in Q2 2026; TTM through Jun 2026 was $503.1 million, a 4.88% decrease from a year earlier, with the FY2025 full-year figure at $526.5 million, down 3.68% from the prior year.
- Research & Development was $129.5 million for Q2 2026 at Perrigo, roughly flat from $129.7 million in the prior quarter.
- Over five years, Research & Development peaked at $171.1 million in Q3 2023 and troughed at $116.6 million in Q4 2025.
- A 5-year average of $142.2 million and a median of $145.4 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development increased 23.82% in 2023 and declined 23.46% in 2024, its largest moves.
- Over 5 years, Research & Development stood at $153.8 million in 2022, then declined by 0.78% to $152.6 million in 2023, then retreated by 23.46% to $116.8 million in 2024, then declined by 0.17% to $116.6 million in 2025, then increased by 11.06% to $129.5 million in 2026.
- The last three Research & Development figures came in at $129.5 million (Q2 2026), $129.7 million (Q1 2026), and $116.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | - |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | - |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | - |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 129.50 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | - |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 13.30 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 1.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 129.50 Mn |
| Mar 28, 2026 | 129.70 Mn |
| Dec 31, 2025 | 116.60 Mn |
| Sep 27, 2025 | 127.30 Mn |
| Jun 28, 2025 | 136.50 Mn |
| Mar 29, 2025 | 146.20 Mn |
| Dec 31, 2024 | 116.80 Mn |
| Sep 28, 2024 | 129.40 Mn |
| Jun 29, 2024 | 150.10 Mn |
| Mar 30, 2024 | 150.30 Mn |
| Dec 31, 2023 | 152.60 Mn |
| Sep 30, 2023 | 150.20 Mn |
| Jul 1, 2023 | 171.10 Mn |
| Apr 1, 2023 | 167.90 Mn |
| Dec 31, 2022 | 153.80 Mn |
| Oct 1, 2022 | 144.50 Mn |
| Jul 2, 2022 | 150.80 Mn |
| Apr 2, 2022 | 135.60 Mn |
| Dec 31, 2021 | 131.40 Mn |
| Oct 2, 2021 | 129.70 Mn |